Rhinitis Pipeline as Novel and Extensive 35+ Therapies Likely to Enter the Treatment Domain

DelveInsight’s, “Rhinitis Pipeline Insight 2023” report provides comprehensive insights about 35+ companies and  35+ pipeline drugs in the Rhinitis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.

Key takeaways from the Rhinitis Pipeline Report

• DelveInsight’s Rhinitis Pipeline report depicts a robust space with 35+ active players working to develop 35+ pipeline therapies for Rhinitis.
• The leading Rhinitis Pipeline Companies are working such as Regeneron, Revolo Biotherapeutics, Anhui Palo Alto Pharmaceuticals Inc, Abdi Ibrahim Pharmaceuticals, Lyra Therapeutics, Inmunotek, Iltoo Pharma, Advagene Biopharma Co. Ltd., AOBiome LLC, Sanofi, Hanmi Pharmaceutical Company Limited, Emergo Therapeutics, Inimmune, Paradigm Biopharmaceuticals, Dong Wha PHARM.CO.Ltd, Siolta Therapeutics, Revelation Biosciences Inc., Allergy Therapeutics, NeuCen BioMed, CSPC ZhongQi Pharmaceutical Technology Co., Ltd., Biomay AG, and others.
• Promising Rhinitis Pipeline Therapies such as Lactobacillus paracasei LP-33, Observational, Levocetirizine, BLX-028914, AD17002, Nasapaque Nasal Solution, Mometasone Furoate Nasal Spray, 50 mcg, MK-8237 tablets, MK-8237 6 DU, and others.
• In the coming years, the Rhinitis market is set to change due to the rising awareness of the disease, and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market.
• The Rhinitis Companies and academics that are working to assess challenges and seek opportunities that could influence Rhinitis R&D. The therapies under development are focused on novel approaches to treat/improve the disease condition.

Recent Developmental Activities in the Rhinitis Pipeline Insight Report

• REGN1908-1909 is a novel cocktail of two fully-human monoclonal IgG antibodies, designed to specifically bind and block the Fel d 1 allergen, thus preventing it from binding and triggering the endogenous antibodies that cause allergies (i.e., Immunoglobulin E, or IgE, antibodies). REGN1908-1909 was invented using Regeneron’s proprietary VelocImmune® technology. Currently, it is in phase III stage of clinical trial evaluation to treat Allergic Rhinitis Due to Cat Allergy.
• IRL201104 was derived from a natural immune-regulatory protein, Mycobacterium tuberculosis Chaperonin 60.1, involved in resetting the immune system. It is expected to provide long-term remission for many allergic diseases. IRL201104 has been shown to quickly and markedly reduce lung infiltration of neutrophils in mice following bronchial challenge with lipopolysaccharide stimulating acute neutrophil activation.  IRL1104 has a very short circulation exposure following IV administration and acts on neutrophil infiltration quickly but in a transient manner, which may mean that it would be able to provide a marked, but temporary, reduction in lung neutrophilia, potentially allowing the lung some respite from the high level of inflammation. Currently, it is in phase II stage of clinical trial evaluation to treat Seasonal Allergic Rhinitis.

Get an overview of the Rhinitis Clinical Trials @ Rhinitis Pipeline Outlook Report

Rhinitis Overview

Rhinitis is a condition that typically involves nasal obstruction or congestion, runny nose or post-nasal drip, itchy nose, and/or sneezing. There are various causes for these symptoms, although they are broadly divided into two types: allergic rhinitis (nasal symptoms related to allergy) and non-allergic rhinitis (nasal symptoms that are not related to allergy). Rhinitis may occur before a case of sinusitis or with sinusitis, a condition where infection or inflammation affects the sinuses.

Rhinitis Pipeline Insight Report

In the Rhinitis pipeline report, detailed description of the drug is given which includes mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, Rhinitis collaborations, licensing, mergers and acquisition, funding, designations and other product related details.

Rhinitis Emerging Drugs Profile

• REGN1908-1909: Regeneron
• IRL201104: Revolo Biotherapeutics

Rhinitis Pipeline Therapeutics Assessment

There are approx. 35+ key companies which are developing the therapies for Rhinitis. The companies which have their Rhinitis drug candidates in the most advanced stage, i.e. phase III include, Regeneron.

Request a sample and discover the recent advances in Rhinitis Treatment Drugs @ Rhinitis Ongoing Clinical Trials Analysis 

Scope of the Rhinitis Pipeline Insight Report

• Coverage- Global
• Rhinitis Pipeline Companies are working such as Regeneron, Revolo Biotherapeutics, Anhui Palo Alto Pharmaceuticals Inc, Abdi Ibrahim Pharmaceuticals, Lyra Therapeutics, Inmunotek, Iltoo Pharma, Advagene Biopharma Co. Ltd., AOBiome LLC, Sanofi, Hanmi Pharmaceutical Company Limited, Emergo Therapeutics, Inimmune, Paradigm Biopharmaceuticals, Dong Wha PHARM.CO.Ltd, Siolta Therapeutics, Revelation Biosciences Inc., Allergy Therapeutics, NeuCen BioMed, CSPC ZhongQi Pharmaceutical Technology Co., Ltd., Biomay AG, and others.
• Rhinitis Pipeline Therapies such as Lactobacillus paracasei LP-33, Observational, Levocetirizine, BLX-028914, AD17002, Nasapaque Nasal Solution, Mometasone Furoate Nasal Spray, 50 mcg, MK-8237 tablets, MK-8237 6 DU, and others

Table of Content

1. Introduction
2. Rhinitis Executive Summary
3. Rhinitis: Overview
4. Rhinitis Pipeline Therapeutics
5. Rhinitis Therapeutic Assessment
6. Rhinitis – DelveInsight’s Analytical Perspective
7. Late Stage Products (Phase III)
8. REGN1908-1909: Regeneron
9. Drug profiles in the detailed report…..
10. Mid Stage Products (Phase II)
11. IRL201104: Revolo Biotherapeutics
12. Drug profiles in the detailed report…..
13. Early Stage Products (Phase I)
14. Drug name: Company name
15. Drug profiles in the detailed report…..
16. Preclinical and Discovery Stage Products
17. Drug name: Company name
18. Drug profiles in the detailed report…..
19. Inactive Products
20. Rhinitis Key Companies
21. Rhinitis Key Products
22. Rhinitis- Unmet Needs
23. Rhinitis- Market Drivers and Barriers
24. Rhinitis- Future Perspectives and Conclusion
25. Rhinitis Analyst Views
26. Rhinitis Key Companies
27. Appendix

For further information on the Rhinitis Pipeline therapeutics, reach out to Rhinitis Treatment Landscape

List of Top Selling Market Research Reports in 2023

Transient Ischemic Attack Market

DelveInsight’s Transient Ischemic Attack Market Insights, Epidemiology, and Market Forecast report delivers an in-depth understanding of the Transient Ischemic Attack forecasted epidemiology.

Surgical Sealant Market

DelveInsight’s ‘Surgical Sealant Tissue -Market Insights, Competitive Landscape and Market Forecast – 2027’ report delivers an in-depth understanding of Surgical Sealant Tissue Market.

Supraventricular Tachycardia Market

DelveInsight’s Supraventricular Tachycardia Market Insights, Epidemiology, and Market Forecast-2032″ report delivers an in-depth understanding of the Supraventricular Tachycardia, historical and forecasted epidemiology as well as the Supraventricular Tachycardia market trends in 7MM.

Stem Cell Market

Stem Cell Market Research Report provides comprehensive insights into the Stem Cell Market Size, Share, Key Companies, Competitive Analysis as well as the Market Forecast.

Scoliosis Market

Scoliosis Market Insights, Epidemiology, Market Forecast report delivers an understanding of Scoliosis, historical and forecasted epidemiology as well as the Scoliosis market trends in 7MM.

Ranibizumab Biosimilars Insight

DelveInsight’s, “Ranibizumab– Biosimilar Insight, 2022” report provides comprehensive insights about 20+ companies and 20+ marketed and pipeline drugs in Ranibizumab Biosimilars landscape.

Pigment Epithelial Detachment Market

DelveInsight’s Pigment Epithelial Detachment Market Insights, Epidemiology, and Market Forecast-2032″ report delivers an in-depth understanding of the Pigment Epithelial Detachment, historical and forecasted epidemiology as well as the Pigment Epithelial Detachment market trends in 7MM.

Percutaneous Arterial Closure Device Market

Percutaneous Arterial Closure Device Market Research Report provides comprehensive insights into the Percutaneous Arterial Closure Device Market Size, Share, Key Companies.

Pediatric Growth Hormone Deficiency PGHD Market

Pediatric Growth Hormone Deficiency Market Insights, Epidemiology, and Market Forecast report delivers an understanding of the Pediatric Growth Hormone Deficiency forecasted epidemiology.

Inflammatory Pain Market

Inflammatory Pain Market Insights, Epidemiology, and Market Forecast-2032 report deliver an understanding of the forecasted epidemiology, and the Inflammatory Pain market trends in 7MM.

Parry-Romberg Syndrome PRS Market

Parry-Romberg Syndrome PRS Market Insights, Epidemiology, and Market Forecast report delivers an understanding of the Parry-Romberg Syndrome PRS, historical and forecasted epidemiology.

Familial Lipoprotein Lipase Deficiency Market

DelveInsight’s Familial Lipoprotein Lipase Deficiency Market Insights, Epidemiology and Market Forecast – 2032 report provides the detailed overview of the disease and in depth.

Myotonic Dystrophy Market

DelveInsight’s Myotonic dystrophy Market Insights, Epidemiology, and Market Forecast-2032″ report delivers an in-depth understanding of the Myotonic dystrophy.

Non-Muscle Invasive Bladder Cancer Market

DelveInsight’s Non-Muscle Invasive Bladder Cancer (NMIBC) Market Insights, Epidemiology, and Market Forecast-2032″ report delivers an in-depth understanding of the Non-Muscle Invasive Bladder Cancer (NMIBC), historical and forecasted epidemiology as well as the Non-Muscle Invasive Bladder Cancer (NMIBC) market trends in 7MM.

Peripheral Nerve Repair Devices Market

DelveInsight’s ‘Peripheral Nerve Repair Devices -Market Insights, Competitive Landscape and Market Forecast – 2027’ report delivers an in-depth understanding.

Ranibizumab Biosimilars Market

DelveInsight’s, “Ranibizumab– Biosimilar Insight, 2022” report provides comprehensive insights about 20+ companies and 20+ marketed and pipeline drugs in Ranibizumab Biosimilars landscape.

Vascular Imaging Market

DelveInsight’s ‘Vascular Imaging Market -Market Insights, Competitive Landscape and Market Forecast – 2027’ report delivers an in-depth understanding of Vascular Imaging Market.

Ewing Sarcoma Market

Ewing Sarcoma Market report delivers an in-depth understanding of the Ewing Sarcoma, historical and forecasted epidemiology as well as the Ewing Sarcoma market trends in 7MM.

Kawasaki Disease Market

Kawasaki Disease Market Insights, Epidemiology, and Market Forecast-2032 report deliver an understanding of the Kawasaki Disease forecasted epidemiology Kawasaki Disease market trends in 7MM.

Partial Paralysis Market

DelveInsight’s Partial Paralysis Market Insights, Epidemiology, and Market Forecast report delivers an in-depth understanding of the Partial Paralysis, historical and forecasted epidemiology.

Pertussis Market

DelveInsight’s Pertussis Market Insights, Epidemiology, and Market Forecast-2032″ report delivers an in-depth understanding.

Digestive System Fistula Market

Digestive System Fistula Market Insights, Epidemiology, and Market Forecast-2032 report delivers an in-depth understanding of the Digestive System Fistula forecasted epidemiology.

Japan Healthcare Outlook

DelveInsight’s,“Japan Healthcare Outlook Report, 2022,” provides comprehensive insights about the healthcare scenario, regulatory policies and reimbursement landscape in Japan.

Pigment Epithelial Detachment Market

DelveInsight’s Pigment Epithelial Detachment Market Insights, Epidemiology, and Market Forecast-2032″ report delivers an in-depth understanding of the Pigment Epithelial Detachment, historical and forecasted epidemiology as well as the Pigment Epithelial Detachment market trends in 7MM.

About Us

DelveInsight is a Business Consulting and Market research company, providing expert business solutions for the healthcare domain and offering quintessential advisory services in the areas of R&D, Strategy Formulation, Operations, Competitive Intelligence, Competitive Landscaping, and Mergers & Acquisitions.

Contact Us

Yash Bhardwaj

info@delveinsight.com